Consent Preferences
Skip to Content

Superior safety profile for decitabine vs chemotherapy for older patient with AML

Acute myeloid leukemia (AML) predominantly occurs in older adults over 65, who often have a lower tolerance to conventional induction chemotherapy (IC) than younger patients. Despite treatment with IC, older patients with AML have poor long-term survival without hematopoietic stem cell transplantation (HSCT).

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top